FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37262511000001100: Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
271121000001115 Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
271141000001113 Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Is a Memantine 20mg tablets true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start